| 2011 | A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results. | LUNG CANCER |
| 2006 | A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer | LUNG CANCER |
| 2014 | A prospective phase II trial of s-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2008 | A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features | ONCOLOGY REPORTS |
| 2024 | Aggressive Local Ablative Radiotherapy Mitigates Progression Risk in Oligometastatic Lung Adenocarcinoma
| CANCER RESEARCH AND TREATMENT |
| 2013 | Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience
| RADIATION ONCOLOGY JOURNAL |
| 2023 | Clinical Outcomes of Thymic Carcinoma: The Role of Radiotherapy Combined with Multimodal Treatments
| CANCERS |
| 2004 | Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
| 2016 | Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer
| CANCER RESEARCH AND TREATMENT |
| 2019 | Different prognosis of patients with esophageal carcinoma with M1a and regional node involvement | DIGESTIVE AND LIVER DISEASE |
| 2017 | Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy
| CANCER RESEARCH AND TREATMENT |
| 2015 | Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma.
| ONCOTARGET |
| 2019 | High-dose versus standard-dose radiation therapy for cervical esophageal cancer: Retrospective single-institution study | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
| 2016 | Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation. | TECHNOLOGY IN CANCER RESEARCH & TREATMENT |
| 2008 | Hypofractionated high-dose intensity-modulated radiotherapy (60 Gy at 2.5 Gy per fraction) for recurrent renal cell carcinoma: A case report
| JOURNAL OF KOREAN MEDICAL SCIENCE |
| 2019 | Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| 2016 | Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
| 2021 | Intracranial failure after hippocampal-avoidance prophylactic cranial irradiation in limited-stage small-cell lung cancer patients
| SCIENTIFIC REPORTS |
| 2014 | Local control may be the key in improving treatment outcomes of esophageal squamous cell carcinoma undergoing concurrent chemoradiation. | DIGESTION |
| 2022 | Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy | RADIOTHERAPY AND ONCOLOGY |
| 2019 | Management of Clinical T1N0M0 Esophageal Cancer
| GUT AND LIVER |
| 2000 | Neoadjuvant Chemotherapy and Radiation for Inoperable cacinoma of the Maxillary Antrum: A matched-control study. | American Journal of Clinical Oncology |
| 2012 | Nutritional status of patients treated with radiotherapy as determined by subjective global assessment
| RADIATION ONCOLOGY JOURNAL |
| 2017 | Optimal Adjuvant Treatment for Curatively Resected Thoracic Esophageal Squamous Cell Carcinoma: A Radiotherapy Perspective
| CANCER RESEARCH AND TREATMENT |
| 2017 | Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study
| RADIATION ONCOLOGY JOURNAL |
| 2016 | Overexpression of SOX2 Is Associated with Better Overall Survival in Squamous Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy
| CANCER RESEARCH AND TREATMENT |
| 2013 | Patterns of care and treatment outcomes for primary thyroid lymphoma: a single institution study
| RADIATION ONCOLOGY JOURNAL |
| 2012 | Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer: implications for postoperative radiotherapy | RADIOTHERAPY AND ONCOLOGY |
| 2015 | Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma
| ONCOTARGET |
| 2012 | Phase II study of cisplatin with irinotecan as induction chemotherapy followed by chemoradiotherapy for unresectable stage III non-small cell lung cancer | ANTICANCER RESEARCH |
| 2007 | Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer
| CANCER |
| 2016 | PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
| ONCOTARGET |
| 2021 | Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Oral Cavity Cancer in the Era of Modern Radiation Techniques
| FRONTIERS IN ONCOLOGY |
| 2021 | Prognostic Significance of Interim Response Evaluation during Definitive Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
| CANCERS |
| 2018 | Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy
| FRONTIERS IN ONCOLOGY |
| 2014 | Prognostic value of neutrophil-to-lymphocyte ratio in patients treated with concurrent chemoradiotherapy for locally advanced oesophageal cancer | DIGESTIVE AND LIVER DISEASE |
| 2019 | Relationship Between Sarcopenia and Prognosis in Patient With Concurrent Chemo-Radiation Therapy for Esophageal Cancer
| FRONTIERS IN ONCOLOGY |
| 2022 | Role of postoperative radiotherapy in resected adenoid cystic carcinoma of the head and neck
| RADIATION ONCOLOGY |
| 2018 | Survival and Functional Outcome after Treatment for Primary Base of Tongue Cancer: A Comparison of Definitive Chemoradiotherapy versus Surgery Followed by Adjuvant Radiotherapy.
| CANCER RESEARCH AND TREATMENT |
| 2016 | The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma
| CANCER RESEARCH AND TREATMENT |
| 2020 | The feasibility and safety of radical esophagectomy in patients receiving neoadjuvant chemoradiotherapy with pembrolizumab for esophageal squamous cell carcinoma
| JOURNAL OF THORACIC DISEASE |
| 2022 | Treatment outcomes and radiotherapy deintensification strategies in human papillomavirus-associated tonsil cancer
| RADIATION ONCOLOGY |
| 2010 | Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
| 2002 | 국한성병기 소세포폐암 환자에서 조기 혹은 지연 교대 방사선-황암제치료의 전향적 연구
| Journal of the Korean Society for Therapeutic Radiology and Oncology |
| 2009 | 비소세포성 폐암으로 수술 후 방사선치료가 시행된 N2병기 환자들에서 다발 부위 종격동 림프절 전이 여부에 따른 N2병기 구분의 임상적 의미
| Journal of the Korean Society for Therapeutic Radiology and Oncology |
